hemoporfin
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
1
Earliest trial started Oct 31, 2019 (NCT04106258)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Studied for
Mechanism of action
- Unspecified targetOXIDATIVE ENZYME
Oxidative enzyme
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05171894 | Phase 2 | Dec 30, 2022 | Shanghai Zhangjiang Biotechnology Limited Company |
| NCT04106258 | Phase 4 | Oct 31, 2019 | Shanghai Zhangjiang Biotechnology Limited Company |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shanghai Zhangjiang Biotechnology Limited Company | For profit | 2 | 2 | 2 | 2019 |
1 organizations
Page 1 / 1